Recent Articles from GlobeNewswire

EINDHOVEN, the Netherlands, Sept. 04, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury and other movement disabilities, today announced that it will release its first-half 2026 financial results and host a webcast with a comprehensive business update on September 9, 2026.

THE WOODLANDS, Texas, Sept. 03, 2026 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced it closed 409 homes in August 2026, including 9 currently or previously leased single-family rental homes. This represents a 9.9% increase compared to 372 homes closed in August 2025.

NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Figure Technology Solutions, Inc. (Nasdaq: FIGR; OPEN: FGRS), the leading blockchain-native capital marketplace for the origination, funding, sale and trading of tokenized assets, today announced the company will be participating in the following upcoming investor conferences:

NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to a new employee.

Châtillon, France, September 3, 2026

Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In Intuit (INTU) To Contact Them Directly To Discuss Their Options

HOUSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Weatherford International plc (NASDAQ: WFRD) (“Weatherford” or the “Company”) today announced that shareholders have approved all proposals required to effect the Company's redomestication from Ireland to Delaware, including approval at both the Board-Convened Scheme Meeting and Extraordinary General Meeting. The shareholder vote marks a significant milestone in Weatherford's continued transformation and advances the Company's plan to establish a corporate structure better aligned with its global operations, long-term strategy, and shareholder base.

Excelsius3D™ – Intelligent 3-in-1 Imaging System Expands Excelsius™ Ecosystem in the European Union

COLUMBUS, Ohio, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Root (NASDAQ: ROOT), the leading technology company in car insurance, today announced it will participate in two upcoming investor conferences in New York City.

First expert consensus establishes standard of care and recognizes full impact of the disease

PicPay continues to accelerate its AI strategy, building on the recent introduction of the company’s ChatGPT plugin to simplify how customers manage their financial lives

Shared brand strategy designed to build greater recognition across affiliated businesses and create a stronger platform for collective growth.

ALAMEDA, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants utilizing its proprietary NanoPortal™ technology, today announced its planned participation in two upcoming investor conferences:

LAKEWOOD, NJ, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (Nasdaq: EZRA) (the “Company”) today announced that its Board of Directors has unanimously adopted a one-year stockholder rights plan. Stockholders do not need to take any action.

SOUTH SAN FRANCISCO, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a biotechnology company focused on developing therapies to counteract the devastating progression of neurodegenerative diseases, today announced that management will participate in the following upcoming investor conferences:

SAN CARLOS, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Attovia Therapeutics, Inc. (“Attovia” or the “Company”) (Nasdaq: ATTO), a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet need, today announced that company management will participate in the following upcoming investor conferences:

Completed upsized initial public offering, including full exercise of the underwriters’ option to purchase additional shares, raising gross proceeds of $397.4 million; together with existing cash expected to fund operations into 2029

Antwerp, Belgium, September 3, 2026 – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab”), a clinical-stage biopharmaceutical company focused on fibro-inflammation, today announced that members of the management team will participate in the following upcoming investor conferences:

SAN ANTONIO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a registered investment advisory firm1 with deep expertise in global markets and specialized sectors ranging from gold and natural resources to airlines, aerospace and defense, today announced net income of $3.1 million, or $0.24 per share, for the fiscal year ended June 30, 2026, compared to a net loss of $334,000, or $(0.03) per share, during the same period a year earlier. Total operating revenue was $10.3 million, a 21% increase over the 12 months ended June 30, 2025.

SAN DIEGO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today announced that Company management will participate in a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15, 2026 at 11:30 a.m. ET.

CAMBRIDGE, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in an analyst-led fireside chat at the Cantor 2026 Global Healthcare Conference in New York City on Thursday, September 10, 2026 at 9:45 a.m. ET.

WALTHAM, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete disease control, greater durability, and a simpler treatment experience for patients, today announced that management will participate in the following upcoming investor conferences:

BOSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX) (Tango Therapeutics or the Company) today announced that, effective September 1, 2026, the Compensation Committee of Tango Therapeutics' Board of Directors granted a non-qualified stock option to purchase 146,500 shares of its common stock and 40,000 restricted stock units (RSUs) to a new employee under Tango Therapeutics' 2023 Inducement Plan.

GREENWICH, Conn., Sept. 03, 2026 (GLOBE NEWSWIRE) -- XPO (NYSE: XPO), a leading provider of freight transportation in North America, today reported certain preliminary LTL segment operating metrics for August 2026. LTL tonnage per day increased 3.7%, as compared with August 2025, attributable to a year-over-year increase of 5.7% in shipments per day and a decrease of 1.8% in weight per shipment. Actual results for August 2026 may vary from the preliminary results reported above.

NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced that management plans to participate in the following upcoming investor conferences:

Luis Jodar, Ph.D., Former Pfizer Chief Medical Officer for Vaccines and Infectious Diseases with Extensive Leadership Experience Across Clinical Development and Medical Affairs for Pneumococcal Conjugate Vaccines Prevnar 13 and Prevnar 20, Joins Vaxcyte as Chief Medical Officer

BOSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced that on September 1, 2026, the Compensation Committee of Praxis’ Board of Directors granted restricted stock unit awards covering an aggregate of 11,535 shares of its common stock to sixty-six new non-executive employees under the Praxis Precision Medicines, Inc. 2024 Inducement Plan (the 2024 Inducement Plan). The restricted stock unit awards were granted as inducements material to the employees’ entering into employment with Praxis in accordance with Nasdaq Listing Rule 5635(c)(4).

MITCHEL FIELD, N.Y., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Frequency Electronics, Inc. (NASDAQ: FEIM), will hold a conference call to discuss results for the first quarter of its fiscal year 2027, ended July 31, 2026, on Thursday, September 10, 2026, at 4:30 PM Eastern Time.

NAARDEN, The Netherlands and MIAMI, Sept. 03, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam’s Board of Directors approved the grant of inducement share options covering an aggregate of 38,900 of NewAmsterdam’s ordinary shares to five non-executive new hires, as well as inducement share options covering 14,000 ordinary shares to Robert Gunning, the Company’s new Vice President, Controller, who serves as the Company’s principal accounting officer. The share options were granted as an inducement material to the employees’ acceptance of employment with NewAmsterdam pursuant to the NewAmsterdam Pharma Company N.V. 2024 Inducement Plan (the “2024 Inducement Plan”) and in accordance with Nasdaq Listing Rule 5635(c)(4).

NEW HAVEN, Conn., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) (“Arvinas” or the “Company”), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that that management will participate in fireside chats at the following upcoming investor conferences:

VANCOUVER, BC and BOSTON, MA, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today announced that the company will present at an upcoming investor conference:

FORT WORTH, Texas, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Marauder Capital ("Marauder") is pleased to announce its acquisition of Montco Power Solutions ("Montco" or the "Company"), an industry-leading power solutions company serving the energy production value chain.

BALA CYNWYD, Pa., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Flagship NDSS NYC Buddy Walk® to celebrate 32 years with 2,500+ people to raise awareness for Down syndrome

WASHINGTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- The Council of Federal Home Loan Banks today issued the following statement attributable to Council President and CEO Ryan Donovan on the appointment of Wil W. Osborn as the new President and CEO of FHLBank Des Moines and the retirement of Kris Williams.

ST. CATHARINES, Ontario, Sept. 03, 2026 (GLOBE NEWSWIRE) -- The News Forum, Canada's independent national news network dedicated to providing balanced perspectives and fostering informed public discussion, is pleased to announce the exclusive broadcast premiere of the new documentary Education Reform: Lessons from England.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Papa John’s To Contact Him Directly To Discuss Their Options

Early borrower data shows $74.2 million in requested volume; mortgage shoppers seek 3x larger loans but fewer than 1 in 10 proceed to a lender, while custodial borrowing costs averaged roughly 600 basis points more than on-chain rates

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

Company demonstrates successful gene delivery and expression in human cartilage cells using internally designed gene therapy platform

-EMPIRE Artist Young Roddo’s Video Features a Live Audience in Roblox’s Biggest Experience Brookhaven with 540K Attendees-

The nationally recognized artist and lifelong veteran advocate joins the first-of-its-kind ground-up modular home build on the nation's front lawn--bringing music, story, and national reach to veteran housing insecurity

Issued on behalf of MindWalk Holdings Corp.

“Swim for Hope” will raise money for a gap in life-threatening equipment and treatment in Kenyan cancer care

PopUp Bagels® is expanding its signature experience across Ohio and Michigan, starting with Cleveland

As Museum Marks 35 Years, Tamela Mann to Perform, Larenz Tate Returns to Host

September examinees will receive official, portable NextGen UBE scores

Issued on behalf of Lake Victoria Gold Ltd.

Huntington Beach, CA, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Liberty Military Housing (Liberty) announced today that it has welcomed Bryan Hunt as the company’s new Chief Financial Officer. In this role, he will lead the company’s accounting, finance, treasury, and information technology departments, strengthening the company’s financial stewardship, overall efficiency, and long-term growth that benefits both Liberty’s employee-owners and the military families that they serve.

Exclusive offering provides automatic warranty coverage and deep insurance premium discounts for ESET MDR customers

More than 200 attendees and government officials, including Tustin's mayor, marked the opening as the institution welcomed its largest entering class in recent years

Chicago, IL, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Alpharus Health has purchased the building at 315 N. Racine Avenue in Chicago's Fulton Market neighborhood to establish a permanent home in the city where the organization's mission first began in 1968. The acquisition marks an important milestone for the nonprofit behavioral healthcare provider, reinforcing its longstanding commitment to Chicago while creating new opportunities to expand access to care for residents across the region.

In partnership with Patriot Mobile, America’s only Christian conservative wireless provider, Reawaken USA launched its national college campus tour by speaking at five Texas universities, Sept. 3, 10 a.m. to 4 p.m. CT.

BOSS Revolution app customers get a 20% discount on their first eSIM purchase, and can save up to 90% compared to international roaming rates

Issued on behalf of Healthy Choice Wellness Corp. / Host Digital Infrastructure

The next-generation machine brings advanced cutting and engraving capabilities, expanded material possibilities, and a more compact design to the Cricut suite of connected machines

LOS ANGELES, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Emberos, the operating system for AI Brand Management, today announced it has raised an oversubscribed $5.5 million seed round. The funding, among the largest seeds raised to date in the AI brand management category, was backed by a private consortium of strategic angel investors and takes the total amount raised to $6.7 million following its pre-seed round in January, 2026, of $1.2 million.

ALBANY, N.Y., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the grand opening of its expanded campus in Albuquerque, New Mexico. Company leaders hosted federal, state and local officials at a ribbon-cutting ceremony, including John Knox, Principal Deputy Assistant Secretary with the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services, Governor Michelle Lujan Grisham and Albuquerque Mayor Tim Keller.

After growing to serve 1,000+ organizations in 90 countries without outside capital, Hi Rasmus will accelerate its next stage of growth while remaining founder-led and centered on helping care teams focus on the child in front of them

•Now compatible with Apple Find My and including active noise cancelling, JBuds Mini ANC pairs everyday listening with added reassurance for life on the go. •JBuds Open Sport 2 delivers JLab’s best ever open-ear sound so listeners can hear their workout and their world with 45-hour battery life and a secure sport fit. •GO Sport ANC combines Active Noise Canceling and 35+ hours of sweatproof playtime built to power your workout. •JLab also unveils new shimmer-finish Jélle Collection for JBuds Lux ANC and JBuds Mini ANC.

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), September 3, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced that it will host a virtual key opinion leader (KOL) event on Wednesday, September 9, 2026 at 10:00 AM ET. The event will highlight the evolving landscape of diagnostic testing for Metabolic dysfunction-Associated SteatoHepatitis (MASH) and will feature Dr. Vlad Ratziu, MD, PhD (Sorbonne University, Pitié-Salpêtrière Hospital, Institute for Cardiometabolism and Nutrition, Paris). To register, click here.

DES MOINES, Iowa, Sept. 03, 2026 (GLOBE NEWSWIRE) -- The Federal Home Loan Bank of Des Moines (FHLB Des Moines or the Bank) today announced that its board of directors has appointed Wil W. Osborn as president and chief executive officer, effective October 1, 2026.

Silver Spring, Md, Sept. 03, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Capstar (nitenpyram) tablets and revised the EUA for Nitenpyram Tablets, the generic version of Capstar, to authorize both products for the prevention and treatment of New World screwworm (NWS) infestations (myiasis) in dogs, puppies, cats, and kittens that weigh at least two pounds and are at least four weeks old. Nitenpyram Tablets were initially authorized in June 2026 for treatment only.

Hosted by financial executive Darla Sierra, the twice-weekly program examines how emotions, habits and personal experiences influence financial decisions

Cubby's largest release yet turns each professor's course into an AI teaching assistant that teaches, tests, and grades their way, and gives every student the practice and feedback of one-on-one instruction

CAMBRIDGE, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today announced the publication in the Journal of the American Medical Association (JAMA) Ophthalmology of the efficacy and safety results from TEASE-1, a randomized, double-masked, placebo-controlled study of investigational oral gildeuretinol as a potential treatment for Stargardt disease. The peer-reviewed publication reports results from the study’s primary efficacy endpoint, two prespecified sensitivity analyses, and safety results over 24 months.

By Light advances Army short range air defense training slated for fielding in Fall 2026

Newly published by Palmetto Publishing, Character First Leadership offers a practical framework rooted in the nine Fruits of the Spirit for developing leaders whose integrity shapes lasting organizational success.

BLOOMFIELD, Conn., Sept. 03, 2026 (GLOBE NEWSWIRE) -- LiquidPiston, Inc., a leading innovator of compact, efficient engine technology and hybrid power systems, today announced individual investors have until Oct. 15 to participate in its Regulation Crowdfunding (Reg CF) investment round.

Following a BBB National Programs’ National Advertising Division challenge brought by VeSync US Corporation, d/b/a Levoit, DREO Incorporated voluntarily discontinued the challenged claims for its pedestal and tower fan products.

LOS ANGELES, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Rackspace Technology, Inc. (“Rackspace” or “the Company”) (NASDAQ: RXT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Capricor Therapeutics, Inc. (“Capricor” or “the Company”) (NASDAQ: CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.